Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Financing Activities (2016 - 2025)

Sonoma Pharmaceuticals has reported Cash from Financing Activities over the past 16 years, most recently at $210000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 70.34% year-over-year to $210000.0; the TTM value through Dec 2025 reached $332000.0, down 90.26%, while the annual FY2025 figure was $3.0 million, 80.79% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $210000.0 at Sonoma Pharmaceuticals, up from -$62000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $6.9 million in Q3 2021 and troughed at -$387000.0 in Q2 2022.
  • A 5-year average of $747500.0 and a median of $232000.0 in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: soared 3148.83% in 2021 and later plummeted 168.68% in 2022.
  • Year by year, Cash from Financing Activities stood at $463000.0 in 2021, then tumbled by 168.68% to -$318000.0 in 2022, then surged by 514.47% to $1.3 million in 2023, then crashed by 46.28% to $708000.0 in 2024, then tumbled by 70.34% to $210000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SNOA at $210000.0 in Q4 2025, -$62000.0 in Q3 2025, and -$58000.0 in Q2 2025.